Stecyk Chrystyna Bedrij 4
4 · VACCINEX, INC. · Filed May 13, 2022
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Stecyk Chrystyna Bedrij
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-12+53,254→ 53,254 totalExercise: $1.12From: 2023-05-12→ Common Stock (53,254 underlying)
Holdings
- 25,087
Stock Option (Right to Buy)
Exercise: $3.95From: 2021-05-14→ Common Stock (25,087 underlying) - 28,586
Stock Option (Right to Buy)
Exercise: $2.15From: 2022-05-11→ Common Stock (28,586 underlying)
Footnotes (3)
- [F1]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
- [F2]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
- [F3]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.